RxSight(RXST) - 2025 Q4 - Earnings Call Transcript

RxSight (NasdaqGM:RXST) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsMark Wilterding - CFOOliver Murovec - Vice President of Investor RelationsRon Kurtz - President and CEOConference Call ParticipantsAdam Maeder - Senior Research AnalystAnthony Petrone - AnalystDanielle Antalffy - AnalystDavid Saxon - AnalystLarry Biegelsen - Senior Medical Technology AnalystSteven Lichtman - AnalystTom Stephan - AnalystNone - AnalystOperatorThank you for standing by. My name is Kate, and I will b ...